{"id":967075,"date":"2026-05-26T16:27:33","date_gmt":"2026-05-26T20:27:33","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-june-investor-conferences\/"},"modified":"2026-05-26T16:27:33","modified_gmt":"2026-05-26T20:27:33","slug":"spyre-therapeutics-to-participate-in-upcoming-june-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-june-investor-conferences\/","title":{"rendered":"Spyre Therapeutics to Participate in Upcoming June Investor Conferences"},"content":{"rendered":"
\n

WALTHAM, Mass., May 26, 2026 (GLOBE NEWSWIRE) — Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (\u201cIBD\u201d) and rheumatic diseases, today announced that management will participate in the following upcoming investor conferences:<\/p>\n

\n
\n Event<\/u>
\n <\/strong>
\n : Jefferies Global Healthcare Conference \u2013 New York<\/strong>
\n
\n
\n Date:<\/u>
\n <\/strong> Wednesday, June 3, 2026
Fireside Time:<\/u><\/strong> 12:15 pm ET<\/p>\n

\n
\n Event:<\/u>
\n <\/strong>
\n Goldman Sachs 47<\/strong>
\n
\n th<\/strong>
\n <\/sup>
\n Annual Global Healthcare Conference \u2013 Miami<\/strong>
\n
\n
\n Date:<\/u>
\n <\/strong> Monday, June 8, 2026
Fireside Time:<\/u><\/strong> 10:00 am ET<\/p>\n

Members of the Spyre management team will also host one-on-one investor meetings during the conferences.<\/p>\n

Live audio webcasts and replays of these events will be available on the Spyre investor events website at https:\/\/ir.spyre.com\/events-and-presentations<\/a>.<\/p>\n

\n About Spyre Therapeutics<\/strong>\n <\/p>\n

Spyre Therapeutics is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (\u201cIBD\u201d) and rheumatic diseases. Spyre’s pipeline includes investigational extended half-life antibodies targeting \u03b14\u03b27, TL1A, and IL-23.<\/p>\n

For more information, visit Spyre’s website at www.spyre.com<\/a>.\u00a0<\/p>\n

\n For Investors:<\/strong>\u00a0\u00a0\u00a0\u00a0\u00a0
Eric McIntyre, Spyre Therapeutics
SVP of Finance and Investor Relations
Eric.mcintyre@spyre.com<\/a>\u00a0<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

WALTHAM, Mass., May 26, 2026 (GLOBE NEWSWIRE) — Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (\u201cIBD\u201d) and rheumatic diseases, today announced that management will participate in the following upcoming investor conferences: Event : Jefferies Global Healthcare Conference \u2013 New York Date: Wednesday, June 3, 2026Fireside Time: 12:15 pm ET Event: Goldman Sachs 47 th Annual Global Healthcare Conference \u2013 Miami Date: Monday, June 8, 2026Fireside Time: 10:00 am ET Members of the Spyre management team will also host one-on-one investor meetings during the conferences. Live audio webcasts and replays of these events will be available on the Spyre investor events website at … <\/p>\n

Continue reading “Spyre Therapeutics to Participate in Upcoming June Investor Conferences”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-967075","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nSpyre Therapeutics to Participate in Upcoming June Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-june-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Spyre Therapeutics to Participate in Upcoming June Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WALTHAM, Mass., May 26, 2026 (GLOBE NEWSWIRE) — Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (\u201cIBD\u201d) and rheumatic diseases, today announced that management will participate in the following upcoming investor conferences: Event : Jefferies Global Healthcare Conference \u2013 New York Date: Wednesday, June 3, 2026Fireside Time: 12:15 pm ET Event: Goldman Sachs 47 th Annual Global Healthcare Conference \u2013 Miami Date: Monday, June 8, 2026Fireside Time: 10:00 am ET Members of the Spyre management team will also host one-on-one investor meetings during the conferences. Live audio webcasts and replays of these events will be available on the Spyre investor events website at … Continue reading "Spyre Therapeutics to Participate in Upcoming June Investor Conferences"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-june-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-26T20:27:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNTUyNCM3NjE4MDc0IzIyOTQ4MTM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyre-therapeutics-to-participate-in-upcoming-june-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyre-therapeutics-to-participate-in-upcoming-june-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Spyre Therapeutics to Participate in Upcoming June Investor Conferences\",\"datePublished\":\"2026-05-26T20:27:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyre-therapeutics-to-participate-in-upcoming-june-investor-conferences\\\/\"},\"wordCount\":191,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyre-therapeutics-to-participate-in-upcoming-june-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyNTUyNCM3NjE4MDc0IzIyOTQ4MTM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyre-therapeutics-to-participate-in-upcoming-june-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyre-therapeutics-to-participate-in-upcoming-june-investor-conferences\\\/\",\"name\":\"Spyre Therapeutics to Participate in Upcoming June Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyre-therapeutics-to-participate-in-upcoming-june-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyre-therapeutics-to-participate-in-upcoming-june-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyNTUyNCM3NjE4MDc0IzIyOTQ4MTM=\",\"datePublished\":\"2026-05-26T20:27:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyre-therapeutics-to-participate-in-upcoming-june-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyre-therapeutics-to-participate-in-upcoming-june-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyre-therapeutics-to-participate-in-upcoming-june-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyNTUyNCM3NjE4MDc0IzIyOTQ4MTM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyNTUyNCM3NjE4MDc0IzIyOTQ4MTM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyre-therapeutics-to-participate-in-upcoming-june-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Spyre Therapeutics to Participate in Upcoming June Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Spyre Therapeutics to Participate in Upcoming June Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-june-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Spyre Therapeutics to Participate in Upcoming June Investor Conferences - Market Newsdesk","og_description":"WALTHAM, Mass., May 26, 2026 (GLOBE NEWSWIRE) — Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (\u201cIBD\u201d) and rheumatic diseases, today announced that management will participate in the following upcoming investor conferences: Event : Jefferies Global Healthcare Conference \u2013 New York Date: Wednesday, June 3, 2026Fireside Time: 12:15 pm ET Event: Goldman Sachs 47 th Annual Global Healthcare Conference \u2013 Miami Date: Monday, June 8, 2026Fireside Time: 10:00 am ET Members of the Spyre management team will also host one-on-one investor meetings during the conferences. Live audio webcasts and replays of these events will be available on the Spyre investor events website at … Continue reading \"Spyre Therapeutics to Participate in Upcoming June Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-june-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-26T20:27:33+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNTUyNCM3NjE4MDc0IzIyOTQ4MTM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-june-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-june-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Spyre Therapeutics to Participate in Upcoming June Investor Conferences","datePublished":"2026-05-26T20:27:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-june-investor-conferences\/"},"wordCount":191,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-june-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNTUyNCM3NjE4MDc0IzIyOTQ4MTM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-june-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-june-investor-conferences\/","name":"Spyre Therapeutics to Participate in Upcoming June Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-june-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-june-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNTUyNCM3NjE4MDc0IzIyOTQ4MTM=","datePublished":"2026-05-26T20:27:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-june-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-june-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-june-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNTUyNCM3NjE4MDc0IzIyOTQ4MTM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNTUyNCM3NjE4MDc0IzIyOTQ4MTM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-june-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Spyre Therapeutics to Participate in Upcoming June Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/967075","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=967075"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/967075\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=967075"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=967075"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=967075"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}